Evaluation of Critical Care Pharmacist Evening Services at an Academic Medical Center
- PMID: 38450349
- PMCID: PMC10913874
- DOI: 10.1177/00185787231207996
Evaluation of Critical Care Pharmacist Evening Services at an Academic Medical Center
Abstract
Purpose: Critical care pharmacists are considered essential members of the healthcare team; however, justification and recruitment of new positions, especially in the evening or weekend shifts, remains a significant challenge. The purpose of this study was to investigate the number of interventions, type of interventions, and associated cost savings with the addition of 1 board certified critical care clinical pharmacist to evening shift. Methods: This was a prospective collection and characterization of 1 evening shift critical care pharmacist's clinical interventions over a 12-week period. Interventions were collected and categorized daily from 13:00 to 22:00 Monday through Friday. After collection was complete, cost savings estimates were calculated using pharmacy wholesaler acquisition cost. Results: Interventions were collected on 52 of 60 weekdays. A total of 510 interventions were collected with an average of 9.8 interventions accepted per day. The most common interventions included transitions of care, medication dose adjustment, and antibiotic de-escalation and the highest proportion of interventions occurred in the medical intensive care unit. An estimated associated cost avoidance of $66 537.80 was calculated for an average of $1279.57 saved per day. Additionally, 22 (4.1%) of interventions were considered high yield interventions upon independent review by 2 pharmacists. Conclusion: The addition of 1 board-certified critical care pharmacist to evening shift resulted in multiple interventions across several categories and a significant cost avoidance when calculated using conservative measures.
Keywords: critical care; medication safety; pharmacy; practice models; quality improvement.
© The Author(s) 2023.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Sikora has received research funding through the Agency for Healthcare Quality and Research (AHRQ) under Award Number R21HS028485 and R01HS029009.
Similar articles
-
Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.Pharm Pract (Granada). 2009 Apr;7(2):81-7. doi: 10.4321/s1886-36552009000200003. Epub 2009 Mar 15. Pharm Pract (Granada). 2009. PMID: 25152782 Free PMC article.
-
Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.J Clin Pharm Ther. 2020 Oct;45(5):1127-1133. doi: 10.1111/jcpt.13195. Epub 2020 Jun 4. J Clin Pharm Ther. 2020. PMID: 32497354
-
Impact of a pediatric clinical pharmacist in the pediatric intensive care unit.Crit Care Med. 2002 Apr;30(4):919-21. doi: 10.1097/00003246-200204000-00035. Crit Care Med. 2002. PMID: 11940770
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
-
Effect of critical care pharmacist's intervention on medication errors: A systematic review and meta-analysis of observational studies.J Crit Care. 2015 Oct;30(5):1101-6. doi: 10.1016/j.jcrc.2015.06.018. Epub 2015 Jun 24. J Crit Care. 2015. PMID: 26260916 Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
